Most Popular in the last 7 days

PerkinElmer agrees to purchase diagnostics company EUROIMMUN for about $1.3 billion

Blood test for circulating free DNA able to identify prostate cancer patients likely to benefit from PARP inhibitor: study

Theranos reaches tentative deal to settle lawsuit from former partner Walgreens: report